Anyone experiencing fatigue, low energy, brain fog, or known B12 deficiency may benefit
Conclusion Published clinical trial data paints a consistent picture of the retatrutide adverse event profile and associated risks: GI events are common, dose-dependent, and generally transient , with rates comparable to other GLP-1 class compounds
Cell 120 : 710 Werner H, Karnieli E, Rauscher FJ, LeRoith D (1996) Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
[9] [12] This partly explains why pharmacological GLP-1 receptor agonists can still be effective in this population
Neumann J, Azatsian K, Hhm C, Hofmann B, Gergs U (2023c) Cardiac effects of ephedrine, norephedrine, mescaline and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations